Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
Pulse rhythm01:30

Pulse rhythm

785
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
785
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The electroclinical phenotype of epilepsy following autoimmune encephalitis.

Epilepsy & behavior reports·2026
Same author

Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancer.

Journal of pathology informatics·2026
Same author

Human hippocampal ripples tune cortical responses based on predicted uncertainty.

Nature neuroscience·2026
Same author

Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus.

Emerging microbes & infections·2026
Same author

Metagenome-assembled genomes from biological soil crusts in sandy sediments of Kitty Todd Nature Preserve, OH, USA.

Microbiology resource announcements·2026

Related Experiment Video

Updated: Jun 25, 2025

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K

Continuous and Unconstrained Tremor Monitoring in Parkinson's Disease Using Supervised Machine Learning and Wearable

Fernando Rodriguez1, Philipp Krauss2,3,4, Jonas Kluckert3,5

  • 1Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Parkinson'S Disease
|May 28, 2024
PubMed
Summary

Wearable sensors can objectively track Parkinson's disease (PD) motor symptoms like tremor. A new machine learning algorithm accurately detects tremor severity during unconstrained activities, improving patient care.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

1.4K

Related Experiment Videos

Last Updated: Jun 25, 2025

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

1.4K

Area of Science:

  • Biomedical Engineering
  • Neurology
  • Machine Learning

Background:

  • Accurate assessment of Parkinson's disease (PD) motor symptoms is crucial for effective management.
  • Wearable sensors offer a promising avenue for continuous, objective symptom monitoring, overcoming limitations of clinical assessments and self-reporting.
  • Assessing symptoms during unconstrained, real-world activities remains a significant challenge for current wearable technologies.

Purpose of the Study:

  • To develop and implement a supervised machine learning algorithm for objective tremor assessment in Parkinson's disease patients.
  • To evaluate the algorithm's performance using sensor data and clinical tremor scores from a real-world dataset.
  • To enable continuous, reliable monitoring of Parkinson's disease symptoms in free-living environments.

Main Methods:

  • A supervised machine learning algorithm, specifically a Support Vector Machine, was developed to predict tremor severity.
  • The algorithm was trained and tested on a 67-hour dataset containing sensor data and clinical tremor scores from 24 Parkinson's patients.
  • Dataset rebalancing techniques were applied to address the inherent imbalance in tremor scores, with 25% of data used for testing.

Main Results:

  • The developed classifier demonstrated robust performance in detecting tremor events, achieving a sensitivity of 0.90 on the test dataset.
  • The overall classification accuracy for tremor severity prediction was high, reaching 0.88.
  • The algorithm proved effective even with modestly sized and imbalanced datasets.

Conclusions:

  • An accurate machine learning classifier for tremor monitoring in free-living settings has been successfully implemented.
  • This technology holds significant clinical value for continuous, objective Parkinson's disease symptom monitoring outside of clinical settings.
  • The advancement facilitates personalized PD management, timely therapeutic adjustments, and ultimately, an improved quality of life for patients.